Skip to main content
SpringerLink
Log in

Lower Extremity Ischemia

  • Chapter
  • First Online:
Practical Cardiology

  • 1394 Accesses

Abstract

Lower extremity limb pain is a common complaint among patients, particularly the elderly. The first step is to define the cause of the lower extremity pain and, in reference to the topic at hand, determine whether ischemic arterial vascular disease is the causal factor. Once other common causes of limb pain such as arthritis, low back pain, and musculoskeletal and neurologic causes are eliminated, the workup for ischemic vascular disease should commence. Peripheral arterial disease (PAD) is by far the most common disease manifestation of systemic atherosclerosis in patients, apart from coronary heart disease, and is estimated to occur in up to 15% of persons older than 55 years [1]. Risk factors for PAD are the same as those for coronary heart disease and include increasing age, tobacco use, hypertension, hyperlipidemia, male gender, hyperhomocystinemia, and diabetes. Other less common causes of lower extremity vascular occlusive disease symptoms include Buerger’s disease (primary small-vessel obliterative arteriopathy associated with tobacco use) and systemic arteritides such as Takayasu’s arteritis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.

    CAS  PubMed  Google Scholar 

  2. Barnes RW. Hemodynamics for the vascular surgeon. Arch Surg. 1980;115(2):216–23.

    CAS  PubMed  Google Scholar 

  3. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–38.

    CAS  PubMed  Google Scholar 

  4. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, de Backer G, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.

    CAS  PubMed  Google Scholar 

  5. Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1(1):65–71.

    CAS  PubMed  Google Scholar 

  6. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120(21):2053–61.

    PubMed  Google Scholar 

  7. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol. 1988;17(2):248–54.

    CAS  PubMed  Google Scholar 

  8. Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol. 1994;140(6):526–34.

    CAS  PubMed  Google Scholar 

  9. Nassoura ZE, Ivatury RR, Simon RJ, Jabbour N, Vinzons A, Stahl W. A reassessment of Doppler pressure indices in the detection of arterial lesions in proximity penetrating injuries of extremities: a prospective study. Am J Emerg Med. 1996;14(2):151–6.

    CAS  PubMed  Google Scholar 

  10. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654.

    Google Scholar 

  11. Bowers BL, Valentine RJ, Myers SI, Chervu A, Clagett GP. The natural history of patients with claudication with toe pressures of 40 mm Hg or less. J Vasc Surg. 1993;18(3):506–11.

    CAS  PubMed  Google Scholar 

  12. Carter SA. Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA. 1969;207(10):1869–74.

    CAS  PubMed  Google Scholar 

  13. Carter SA, Tate RB. Value of toe pulse waves in addition to systolic pressures in the assessment of the severity of peripheral arterial disease and critical limb ischemia. J Vasc Surg. 1996;24(2):258–65.

    CAS  PubMed  Google Scholar 

  14. Carter SA, Tate RB. The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene. J Vasc Surg. 2001;33(4):708–14.

    CAS  PubMed  Google Scholar 

  15. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med. 2001;18(7):528–32.

    CAS  PubMed  Google Scholar 

  16. Ramsey DE, Manke DA, Sumner DS. Toe blood pressure. A valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg (Torino). 1983;24(1):43–8.

    CAS  Google Scholar 

  17. Edwards AJ, Wells IP, Roobottom CA. Multidetector row CT angiography of the lower limb arteries: a prospective comparison of volume-rendered techniques and intra-arterial digital subtraction angiography. Clin Radiol. 2005;60(1):85–95.

    CAS  PubMed  Google Scholar 

  18. Edwards AM, Dymock D, Woodward MJ, Jenkinson HF. Genetic relatedness and phenotypic characteristics of Treponema associated with human periodontal tissues and ruminant foot disease. Microbiology. 2003;149(Pt 5):1083–93.

    CAS  PubMed  Google Scholar 

  19. Melliere D, Cron J, Allaire E, Desgranges P, Becquemin JP. Indications and benefits of simultaneous endoluminal balloon angioplasty and open surgery during elective lower limb revascularization. Cardiovasc Surg. 1999;7(2):242–6.

    CAS  PubMed  Google Scholar 

  20. Aliawadi G, Stanley JC, Williams DW, Dimick JB, Henke PK, Upchurch GR. Gadolinium as a non-nephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg. 2003;37:346–52.

    Google Scholar 

  21. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180–4.

    CAS  PubMed  Google Scholar 

  22. Baum RA, Rutter CM, Sunshine JH, Blebea JS, Blebea J, Carpenter JP, Dickey KW, Quinn SF, Gomes AS, Grist TM, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA. 1995;274(11):875–80.

    CAS  PubMed  Google Scholar 

  23. Owen RS, Carpenter JP, Baum RA, Perloff LJ, Cope C. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med. 1992;326(24):1577–81.

    CAS  PubMed  Google Scholar 

  24. Meaney JF, Ridgway JP, Chakraverty S, Robertson I, Kessel D, Radjenovic A, Kouwenhoven M, Kassner A, Smith MA. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology. 1999;211(1):59–67.

    CAS  PubMed  Google Scholar 

  25. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995;274(12):975–80.

    CAS  PubMed  Google Scholar 

  26. Faulkner KW, House AK, Castleden WM. The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust. 1983;1(5):217–9.

    CAS  PubMed  Google Scholar 

  27. Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand. 1987;221(3):253–60.

    CAS  PubMed  Google Scholar 

  28. Lassila R, Lepantalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand. 1988;154(11–12):635–40.

    CAS  PubMed  Google Scholar 

  29. The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline [see comment]. JAMA. 1996;275(16):1270–80.

    Google Scholar 

  30. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340(9):685–91.

    CAS  PubMed  Google Scholar 

  31. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55.

    CAS  PubMed  Google Scholar 

  32. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56–63.

    CAS  PubMed  Google Scholar 

  33. Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med. 2006;166(15):1561–8.

    PubMed  Google Scholar 

  34. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–53.

    Google Scholar 

  35. Heart Protection Study Collaborative G: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial [see comment] [summary for patients in Curr Cardiol Rep. 2002;4(6):486–7; PMID: 12379169]. Lancet. 2002;360(9326):7–22.

    Google Scholar 

  36. Heart Protection Study Collaborative G. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45(4):645–54; discussion 653–644.

    Google Scholar 

  37. Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart LaBI, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.[erratum appears in Circulation. 2004;110(6):763]. Circulation. 2004;110(2):227–39.

    Google Scholar 

  38. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341(6):410–8.

    CAS  PubMed  Google Scholar 

  39. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341(6):410–8.

    CAS  PubMed  Google Scholar 

  40. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. [see comment] [erratum appears in JAMA. 2003;290(2):197]. JAMA. 2003;289(19):2560–72.

    CAS  Google Scholar 

  41. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. [see comment] [erratum appears in 2000;342(18):1376]. N Engl J Med. 2000;342(3):145–53.

    CAS  PubMed  Google Scholar 

  42. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM. Veterans Affairs Site I: effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. [see comment]. JAMA. 2007;298(10):1163–70.

    CAS  PubMed  Google Scholar 

  43. Homocysteine Studies C. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis [see comment]. JAMA. 2002;288(16):2015–22.

    Google Scholar 

  44. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang C-H, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial [see comment]. JAMA. 2004;291(5):565–75.

    CAS  PubMed  Google Scholar 

  45. Dawson DL, Cutler BS, Hiatt WR, Hobson RW II, Martin JD, Bortey EB, Forbes WP, Strandness DE Jr. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000;109(7):523–30.

    CAS  PubMed  Google Scholar 

  46. Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE Jr, Bortey EB, Forbes WP. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med. 1999;159(17):2041–50.

    CAS  PubMed  Google Scholar 

  47. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002;90(12):1314–9.

    CAS  PubMed  Google Scholar 

  48. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol. 1999;34(5):1618–24.

    CAS  PubMed  Google Scholar 

  49. Brevetti G, Perna S, Sabba C, Martone VD, Condorelli M. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol. 1995;26(6):1411–6.

    CAS  PubMed  Google Scholar 

  50. Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med. 2000;5(1):11–9.

    CAS  PubMed  Google Scholar 

  51. Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation. 2007;116(2):188–95.

    CAS  PubMed  Google Scholar 

  52. Eliason JL, Wainess RM, Proctor MP, Dimick JB, Cowan JAJ, Upchurch GR, Stanley JC, Henke PK. A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg. 2003;238:382–90.

    PubMed  PubMed Central  Google Scholar 

  53. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med. 1998;338(16):1105–11.

    CAS  PubMed  Google Scholar 

  54. Weaver FA, Comerota AJ, Youngblood M, Froehlich J, Hosking JD, Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg. 1996;24(4):513–21; discussion 521–513.

    CAS  PubMed  Google Scholar 

  55. Leng GC, Davis M, Baker D. Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev. 2000;3:CD002000.

    Google Scholar 

  56. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.

    CAS  PubMed  Google Scholar 

  57. Johnston KW, Rae M, Hogg-Johnston SA, Colapinto RF, Walker PM, Baird RJ, Sniderman KW, Kalman P. 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg. 1987;206(4):403–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC, Mali WP. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998;351(9110):1153–9.

    CAS  PubMed  Google Scholar 

  59. Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg. 1997;25(1):74–83.

    CAS  PubMed  Google Scholar 

  60. Powell RJ, Fillinger M, Walsh DB, Zwolak R, Cronenwett JL. Predicting outcome of angioplasty and selective stenting of multisegment iliac artery occlusive disease. J Vasc Surg. 2000;32(3):564–9.

    CAS  PubMed  Google Scholar 

  61. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol. 1998;21(5):361–6.

    CAS  PubMed  Google Scholar 

  62. Eagleton MJ, Illig KA, Green RM, Ouriel K, Riggs PN, DeWeese JA. Impact of inflow reconstruction on infrainguinal bypass. J Vasc Surg. 1997;26(6):928–36; discussion 937–928.

    CAS  PubMed  Google Scholar 

  63. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization. Veterans Administration Cooperative Study Group 141. Arch Surg. 1988;123(4):434–8.

    Google Scholar 

  64. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, Towne JB, Bernhard VM, Bonier P, Flinn WR, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3(1):104–14.

    CAS  PubMed  Google Scholar 

  65. Neville RF, Tempesta B, Sidway AN. Tibial bypass for limb salvage using polytetrafluoroethylene and a distal vein patch. J Vasc Surg. 2001;33(2):266–71; discussion 271–262.

    CAS  PubMed  Google Scholar 

  66. Harris PL, Veith FJ, Shanik GD, Nott D, Wengerter KR, Moore DJ. Prospective randomized comparison of in situ and reversed infrapopliteal vein grafts. Br J Surg. 1993;80(2):173–6.

    CAS  PubMed  Google Scholar 

  67. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg. 1990;11(2):193–205; discussion 205–196.

    PubMed  Google Scholar 

  68. Donaldson MC, Whittemore AD, Mannick JA. Further experience with an all-autogenous tissue policy for infrainguinal reconstruction. J Vasc Surg. 1993;18(1):41–8.

    CAS  PubMed  Google Scholar 

  69. Tangelder MJ, Lawson JA, Algra A, Eikelboom BC. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery. J Vasc Surg. 1999;30(4):701–9.

    CAS  PubMed  Google Scholar 

  70. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706–17.

    CAS  Google Scholar 

  71. Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J. 2009;30(2):192–201.

    CAS  PubMed  Google Scholar 

  72. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007;49(19):1982–8.

    PubMed  Google Scholar 

  73. Catalano M, Born G, Peto R. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med. 2007;261(3):276–84.

    CAS  PubMed  Google Scholar 

  74. Becquemin JP. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine apres Pontage Femoro-Poplite and the Association Universitaire de Recherche en Chirurgie. N Engl J Med. 1997;337(24):1726–31.

    CAS  PubMed  Google Scholar 

  75. Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357(3):217–27.

    CAS  PubMed  Google Scholar 

  76. Henke PK, Sukheepod P, Proctor MC, Upchurch GR Jr, Stanley JC. Clinical relevance of peripheral vascular occlusive disease in patients with rheumatoid arthritis and systemic lupus erythematosus. J Vasc Surg. 2003;38(1):111–5.

    PubMed  Google Scholar 

  77. Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, Conte MS. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004;39(6):1178–85.

    PubMed  PubMed Central  Google Scholar 

  78. Cheng SW, Ting AC, Lau H, Wong J. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg. 2000;14(2):158–65.

    CAS  PubMed  Google Scholar 

  79. Burek KA, Sutton-Tyrrell K, Brooks MM, Naydeck B, Keller N, Sellers MA, Roubin G, Jandova R, Rihal CS. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 1999;34(3):716–21.

    CAS  PubMed  Google Scholar 

  80. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl):5S–17S.

    PubMed  Google Scholar 

  81. Kalra M, Gloviczki P, Bower TC, Panneton JM, Harmsen WS, Jenkins GD, Stanson AW, Toomey BJ, Canton LG. Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg. 2001;33(1):6–16.

    CAS  PubMed  Google Scholar 

  82. Hallett JW Jr, Byrne J, Gayari MM, Ilstrup DM, Jacobsen SJ, Gray DT. Impact of arterial surgery and balloon angioplasty on amputation: a population-based study of 1155 procedures between 1973 and 1992. J Vasc Surg. 1997;25(1):29–38.

    PubMed  Google Scholar 

  83. Dossa CD, Shepard AD, Amos AM, Kupin WL, Reddy DJ, Elliott JP, Wilczwski JM, Ernst CB. Results of lower extremity amputations in patients with end-stage renal disease. J Vasc Surg. 1994;20(1):14–9.

    CAS  PubMed  Google Scholar 

  84. AbuRahma AF, Woodruff BA, Lucente FC. Edema after femoropopliteal bypass surgery: lymphatic and venous theories of causation. J Vasc Surg. 1990;11(3):461–7.

    CAS  PubMed  Google Scholar 

  85. Abou-Zamzam AM Jr, Lee RW, Moneta GL, Taylor LM Jr, Porter JM. Functional outcome after infrainguinal bypass for limb salvage. J Vasc Surg. 1997;25(2):287–95; discussion 295–287.

    PubMed  Google Scholar 

  86. Nicoloff AD, Taylor LM Jr, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg. 1998;27(2):256–63; discussion 264–256.

    CAS  PubMed  Google Scholar 

  87. Dawson I, Van Bockel JH. Outcome measures after lower extremity bypass surgery: there is more than just patency. Br J Surg. 1999;86(9):1105–6.

    CAS  PubMed  Google Scholar 

  88. Calligaro KD, Musser DJ, Chen AY, Dougherty MJ, McAffee-Bennett S, Doerr KJ, Raviola CA, DeLaurentis DA. Duplex ultrasonography to diagnose failing arterial prosthetic grafts. Surgery. 1996;120(3):455–9.

    CAS  PubMed  Google Scholar 

  89. Visser K, Idu MM, Buth J, Engel GL, Hunink MG. Duplex scan surveillance during the first year after infrainguinal autologous vein bypass grafting surgery: costs and clinical outcomes compared with other surveillance programs. J Vasc Surg. 2001;33(1):123–30.

    CAS  PubMed  Google Scholar 

  90. Lundell A, Lindblad B, Bergqvist D, Hansen F. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg. 1995;21(1):26–33; discussion 33–24.

    CAS  PubMed  Google Scholar 

  91. Bandyk DF, Johnson BL, Gupta AK, Esses GE. Nature and management of duplex abnormalities encountered during infrainguinal vein bypass grafting. J Vasc Surg. 1996;24(3):430–6; discussion 437–438.

    CAS  PubMed  Google Scholar 

  92. Gibson KD, Caps MT, Gillen D, Bergelin RO, Primozich J, Strandness DE Jr. Identification of factors predictive of lower extremity vein graft thrombosis. J Vasc Surg. 2001;33(1):24–31.

    CAS  PubMed  Google Scholar 

  93. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347(24):1941–51.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michigan Medicine, University of Michigan, Ann Arbor, MI, USA

    Katherine A. Gallagher

  2. Division of Vascular Surgery, Department of Surgery, University of Wisconsin, Madison, WI, USA

    John E. Rectenwald

  3. University of Michigan Medical School, Ann Arbor, MI, USA

    James B. Froehlich

  4. Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA

    Peter K. Henke

  5. Cardiovascular Center, Ann Arbor, MI, USA

    Peter K. Henke

Authors
  1. Katherine A. Gallagher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John E. Rectenwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James B. Froehlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter K. Henke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter K. Henke .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

    Ragavendra R. Baliga

  2. University of Michigan Health System, Cardiovascular Center, Ann Arbor, MI, USA

    Kim A. Eagle

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gallagher, K.A., Rectenwald, J.E., Froehlich, J.B., Henke, P.K. (2020). Lower Extremity Ischemia. In: Baliga, R., Eagle, K. (eds) Practical Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-28328-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28328-5_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28326-1

  • Online ISBN: 978-3-030-28328-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation